(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 2.15%-863.95K | 44.45%-681.06K | -72.09%-975.25K | 2.03%-3.2M | -221.54%-521.85K | -28.59%-882.93K | -9.82%-1.23M | 56.36%-566.7K | -4.41%-3.26M | 71.41%-162.29K |
Net income from continuing operations | 22.13%-1.31M | 11.87%-1.52M | -29.61%-1.66M | -62.15%-7.32M | -1,144.40%-2.63M | -71.10%-1.68M | -38.25%-1.73M | 49.52%-1.28M | 8.61%-4.52M | 119.99%251.79K |
Operating gains losses | -65.86%67.9K | -77.01%35.96K | 200.23%324.07K | 161.64%1.74M | 162.59%1.28M | 177.22%198.9K | 157.96%156.38K | 142.24%107.94K | -419.10%-2.83M | -563.36%-2.05M |
Depreciation and amortization | 89.68%251.11K | 77.15%233.15K | 75.83%233.44K | 17.97%628.94K | 74.88%232.17K | -0.73%132.39K | -1.33%131.61K | -0.63%132.77K | 30.79%533.12K | -67.27%132.77K |
Remuneration paid in stock | 50.26%62.11K | --0 | --0 | -88.97%227.36K | -99.97%202 | -27.04%41.33K | 310.94%147.3K | -97.14%38.52K | 101.65%2.06M | 329.24%621.2K |
Other non cashItems | 28.84%249.51K | 16.34%222.72K | 20.13%225.97K | 15.04%764.04K | 16.82%190.82K | 13.98%193.66K | -42.14%191.45K | 752,356.00%188.11K | 301,787.27%664.15K | 282,922.37%163.35K |
Change In working capital | -177.87%-183.01K | 386.02%351.54K | -293.75%-102.4K | 188.59%568.8K | 184.61%403.82K | 63.49%235.04K | -28.76%-122.91K | 665.83%52.85K | -60.33%197.1K | -67.92%141.89K |
-Change in receivables | -88.92%5.88K | 138.58%6.99K | 354.43%53.66K | -16.12%-34.88K | -803.64%-48.7K | 646.78%53.03K | 39.90%-18.12K | -1,222.19%-21.09K | -35.90%-30.04K | 64.39%-5.39K |
-Change in prepaid assets | -101.49%-2.99K | 127.60%62.72K | -50.59%-119.19K | -3,591.05%-70.09K | 101.37%35.02K | 812.15%201.24K | -2,707.07%-227.21K | -58.08%-79.15K | 94.03%-1.9K | -5.33%17.39K |
-Change in payables and accrued expense | -1,041.15%-164.45K | 378.72%358.23K | -124.62%-44.73K | 157.63%677.85K | 302.60%435.71K | -112.07%-14.41K | 275.16%74.83K | 1,066.79%181.73K | -52.23%263.12K | -75.35%108.22K |
-Change in other working capital | -344.98%-21.45K | -260.52%-76.4K | 127.48%7.87K | 88.03%-4.08K | -184.07%-18.21K | -0.96%-4.82K | 150.65%47.59K | -166.62%-28.64K | ---34.09K | --21.66K |
Dividends received (cash flow from operating activities) | --0 | --0 | --0 | -69.43%191K | --0 | --0 | --0 | --191K | 420.74%624.83K | 25,141.84%573.16K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 2.15%-863.95K | 44.45%-681.06K | -72.09%-975.25K | 2.03%-3.2M | -221.54%-521.85K | -28.59%-882.93K | -9.82%-1.23M | 56.36%-566.7K | -4.41%-3.26M | 71.41%-162.29K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -1,163.73%-141.63K | 0 | 98.04%-45.27K | 2.25%19.11K | 78.09%-42.15K | -340.18%-11.21K | 99.48%-11.03K | 12.65%-2.31M | 110.05%18.69K |
Net PPE purchase and sale | ---- | ---- | ---- | -102.79%-1.75K | -60.94%24.47K | ---- | ---- | ---- | 1,779.69%62.65K | 1,473.85%62.65K |
Net intangibles purchas and sale | --0 | --0 | --0 | 85.74%-56.42K | 87.80%-5.36K | 91.72%-15.93K | -616.59%-24.1K | 93.28%-11.03K | 51.45%-395.68K | 70.74%-43.96K |
Net investment purchase and sale | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- | -7.89%-1.97M | --0 |
Net other investing changes | ---- | ---- | ---- | --12.89K | --0 | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | -1,163.73%-141.63K | --0 | 98.04%-45.27K | 2.25%19.11K | 78.09%-42.15K | -340.18%-11.21K | 99.48%-11.03K | 12.65%-2.31M | 110.05%18.69K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1.08M | -83.79%207.78K | 0.12%1.65M | 185.89%2.93M | 0 | 0 | 2,907.00%1.28M | 82.52%1.65M | -87.29%1.02M | -99.46%22.19K |
Net issuance payments of debt | --1.08M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net common stock issuance | --0 | -94.84%66.13K | -0.11%1.66M | 497.92%2.94M | --0 | --0 | 22,042.38%1.28M | 348.69%1.66M | -88.26%491.67K | -89.04%22.19K |
Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -86.25%533.55K | --0 |
Net other financing activities | --0 | --0 | 35.38%-6.99K | -1,457.64%-10.81K | --0 | --0 | --0 | -1,457.64%-10.81K | 89.09%-694 | --0 |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --1.08M | -83.79%207.78K | 0.12%1.65M | 185.89%2.93M | --0 | --0 | 2,907.00%1.28M | 82.52%1.65M | -87.29%1.02M | -99.46%22.19K |
Net cash flow | ||||||||||
Beginning cash position | -93.57%94.2K | -50.52%709.82K | -89.55%36.53K | -92.86%349.64K | 14.32%538.6K | 13.31%1.46M | -40.86%1.43M | -92.86%349.64K | 75.98%4.9M | -72.82%471.15K |
Current changes in cash | 122.81%211.05K | -1,469.08%-614.91K | -37.00%673.61K | 93.10%-313.73K | -314.07%-502.74K | -12.60%-925.08K | 104.20%44.91K | 142.18%1.07M | -298.26%-4.55M | -103.65%-121.41K |
Effect of exchange rate changes | 42.19%-359 | 95.35%-710 | -101.97%-313 | 84.18%617 | 804.26%662 | -282.65%-621 | 76.26%-15.29K | -75.40%15.86K | 100.19%335 | 99.94%-94 |
End cash Position | -43.39%304.9K | -93.57%94.2K | -50.52%709.82K | -89.55%36.53K | -89.55%36.53K | 14.32%538.6K | 13.31%1.46M | -40.86%1.43M | -92.86%349.64K | -92.86%349.64K |
Free cash from | 6.61%-863.95K | 45.52%-681.06K | -68.81%-975.25K | 11.04%-3.26M | -143.75%-502.74K | -5.25%-925.08K | -12.45%-1.25M | 60.50%-577.73K | 8.12%-3.66M | 71.55%-206.25K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data